StockWatch
·
Biotechnology: Pharmaceutical Preparations
OtherJun 16, 2026, 04:43 PM

Pulmatrix Files 10-K Amendment with Updated Certifications and Financials

AI Summary

Pulmatrix, Inc. has filed Amendment No. 1 to its Form 10-K, primarily to include updated certifications from its principal officers and to re-include Part II, Item 8 of the original filing. The amendment also lists various exhibits, including financial statements for the years ended December 31, 2025 and 2024, and reports from its auditors. Key financial figures show a decrease in total assets and a reduced net loss for 2025 compared to 2024. The company is proceeding with a merger with Cullgen Inc., which is subject to closing conditions and regulatory approvals.

Key Highlights

  • Pulmatrix, Inc. filed an amendment (Amendment No. 1) to its Original Filing on Form 10-K.
  • The amendment includes updated certifications from the principal executive and financial officers.
  • Part II, Item 8 (Financial Statements) and Part IV, Item 15 (Exhibits) were addressed in the amendment.
  • The filing lists various exhibits including agreements, plans, and financial statements for the years ended December 31, 2025 and 2024.
  • Auditors CBIZ CPAs P.C. and Marcum LLP provided reports on the financial statements.
  • Consolidated Balance Sheets show total assets of $4,139 thousand for Dec 31, 2025, down from $9,943 thousand for Dec 31, 2024.
  • Consolidated Statements of Operations show a net loss of $5,162 thousand for 2025, compared to a net loss of $9,559 thousand for 2024.
  • The company is involved in a merger with Cullgen Inc., with an expected closing subject to regulatory approvals.